Profile | GDS5420 / 222633_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 316.4 | 60 |
GSM1296119 | B_lesional_pre-dose | 2161.91 | 90 |
GSM1296076 | C_lesional_pre-dose | 1349.49 | 83 |
GSM1296092 | D_lesional_pre-dose | 1113.72 | 80 |
GSM1296103 | E_lesional_pre-dose | 776.28 | 75 |
GSM1296078 | F_lesional_pre-dose | 1378.75 | 83 |
GSM1296107 | G_lesional_pre-dose | 2475.68 | 92 |
GSM1296109 | H_lesional_pre-dose | 1528.75 | 86 |
GSM1296080 | I_lesional_pre-dose | 400.93 | 64 |
GSM1296090 | J_lesional_pre-dose | 1204.91 | 82 |
GSM1296074 | K_lesional_pre-dose | 1326.91 | 83 |
GSM1296111 | L_lesional_pre-dose | 2386.22 | 91 |
GSM1296099 | M_lesional_pre-dose | 711.51 | 73 |
GSM1296086 | O_lesional_pre-dose | 869.21 | 77 |
GSM1296117 | P_lesional_pre-dose | 2354.56 | 91 |
GSM1296113 | Q_lesional_pre-dose | 2091.56 | 90 |
GSM1296096 | R_lesional_pre-dose | 622.29 | 71 |
GSM1296105 | S_lesional_pre-dose | 500.03 | 67 |
GSM1296098 | T_lesional_pre-dose | 390.6 | 63 |
GSM1296101 | U_lesional_pre-dose | 362.35 | 62 |
GSM1296121 | V_lesional_pre-dose | 2199.86 | 90 |
GSM1296088 | W_lesional_pre-dose | 686.55 | 73 |
GSM1296082 | X_lesional_pre-dose | 1426.66 | 84 |
GSM1296115 | Y_lesional_pre-dose | 2399.13 | 91 |
GSM1296084 | Z_lesional_pre-dose | 652.88 | 72 |
GSM1296072 | B_lesional_day8 | 1572.25 | 86 |
GSM1296069 | L_lesional_day8 | 2381.24 | 92 |
GSM1296071 | P_lesional_day8 | 1862.7 | 89 |
GSM1296070 | Y_lesional_day8 | 2320.49 | 92 |
GSM1296073 | V_lesional_day8 | 1906.97 | 88 |
GSM1296034 | A_lesional_day15 | 185.71 | 50 |
GSM1296041 | G_lesional_day15 | 2648.11 | 92 |
GSM1296035 | R_lesional_day15 | 537.65 | 69 |
GSM1296038 | U_lesional_day15 | 922.6 | 78 |
GSM1296047 | B_lesional_day15 | 1867.9 | 89 |
GSM1296039 | E_lesional_day15 | 1017.61 | 79 |
GSM1296042 | H_lesional_day15 | 2602.63 | 93 |
GSM1296043 | L_lesional_day15 | 2175.04 | 91 |
GSM1296037 | M_lesional_day15 | 400.84 | 63 |
GSM1296046 | P_lesional_day15 | 2028.95 | 90 |
GSM1296044 | Q_lesional_day15 | 2356.63 | 92 |
GSM1296045 | Y_lesional_day15 | 2313.46 | 92 |
GSM1296025 | C_lesional_day15 | 279.95 | 58 |
GSM1296033 | D_lesional_day15 | 660.38 | 72 |
GSM1296027 | I_lesional_day15 | 610.85 | 71 |
GSM1296032 | J_lesional_day15 | 766.95 | 75 |
GSM1296024 | K_lesional_day15 | 288.73 | 59 |
GSM1296031 | W_lesional_day15 | 627.36 | 71 |
GSM1296028 | X_lesional_day15 | 543.15 | 69 |
GSM1296029 | Z_lesional_day15 | 479.35 | 67 |
GSM1296026 | F_lesional_day15 | 480.04 | 67 |
GSM1296030 | O_lesional_day15 | 630.89 | 71 |
GSM1296040 | S_lesional_day15 | 529.71 | 68 |
GSM1296036 | T_lesional_day15 | 479.53 | 66 |
GSM1296048 | V_lesional_day15 | 1481.56 | 85 |
GSM1296059 | A_lesional_day43 | 562.12 | 70 |
GSM1296066 | G_lesional_day43 | 2409.21 | 92 |
GSM1296060 | R_lesional_day43 | 588.05 | 70 |
GSM1296063 | U_lesional_day43 | 982.21 | 79 |
GSM1296064 | E_lesional_day43 | 1159.62 | 81 |
GSM1296067 | H_lesional_day43 | 1536.11 | 86 |
GSM1296062 | M_lesional_day43 | 328.01 | 60 |
GSM1296068 | Q_lesional_day43 | 2125.43 | 91 |
GSM1296050 | C_lesional_day43 | 781.4 | 75 |
GSM1296057 | D_lesional_day43 | 399.88 | 64 |
GSM1296052 | I_lesional_day43 | 658.43 | 72 |
GSM1296054 | J_lesional_day43 | 397.38 | 63 |
GSM1296049 | K_lesional_day43 | 344.3 | 62 |
GSM1296055 | W_lesional_day43 | 682.78 | 73 |
GSM1296053 | X_lesional_day43 | 386.26 | 63 |
GSM1296058 | Z_lesional_day43 | 358.16 | 62 |
GSM1296051 | F_lesional_day43 | 985.21 | 79 |
GSM1296056 | O_lesional_day43 | 500.61 | 68 |
GSM1296065 | S_lesional_day43 | 909.35 | 77 |
GSM1296061 | T_lesional_day43 | 271.2 | 57 |
GSM1296095 | A_non-lesional_pre-dose | 1018.11 | 79 |
GSM1296120 | B_non-lesional_pre-dose | 2072.08 | 90 |
GSM1296077 | C_non-lesional_pre-dose | 347.59 | 62 |
GSM1296093 | D_non-lesional_pre-dose | 308.63 | 59 |
GSM1296104 | E_non-lesional_pre-dose | 799.56 | 76 |
GSM1296079 | F_non-lesional_pre-dose | 474.71 | 67 |
GSM1296108 | G_non-lesional_pre-dose | 2568.1 | 92 |
GSM1296110 | H_non-lesional_pre-dose | 1836.59 | 89 |
GSM1296081 | I_non-lesional_pre-dose | 313.26 | 60 |
GSM1296091 | J_non-lesional_pre-dose | 897.46 | 77 |
GSM1296075 | K_non-lesional_pre-dose | 998.33 | 79 |
GSM1296112 | L_non-lesional_pre-dose | 2035.26 | 91 |
GSM1296100 | M_non-lesional_pre-dose | 355.69 | 61 |
GSM1296087 | O_non-lesional_pre-dose | 497.38 | 68 |
GSM1296118 | P_non-lesional_pre-dose | 1945.49 | 90 |
GSM1296114 | Q_non-lesional_pre-dose | 2577.99 | 93 |
GSM1296097 | R_non-lesional_pre-dose | 590.98 | 71 |
GSM1296106 | S_non-lesional_pre-dose | 592.05 | 70 |
GSM1296102 | U_non-lesional_pre-dose | 339.17 | 60 |
GSM1296122 | V_non-lesional_pre-dose | 1453.36 | 85 |
GSM1296089 | W_non-lesional_pre-dose | 670.33 | 72 |
GSM1296083 | X_non-lesional_pre-dose | 293.97 | 58 |
GSM1296116 | Y_non-lesional_pre-dose | 2393.99 | 92 |
GSM1296085 | Z_non-lesional_pre-dose | 451.23 | 66 |